TechBio Founders #4: Targeting the core drivers of age-related diseases with Daniel Oliver, CEO Rejuvenate Bio episode artwork

EPISODE · Jan 4, 2023 · 42 MIN

TechBio Founders #4: Targeting the core drivers of age-related diseases with Daniel Oliver, CEO Rejuvenate Bio

from Next Sequence · host Daniel Oliver, Loretta TIOIELA

Rejuvenate Bio is developing novel therapies to treat aging and age-related diseases through innovative targeted gene therapies and developing treatments to reverse aging and address multiple age-related diseases.

NOW PLAYING

TechBio Founders #4: Targeting the core drivers of age-related diseases with Daniel Oliver, CEO Rejuvenate Bio

0:00 42:22

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Next Sequence?

This episode is 42 minutes long.

When was this Next Sequence episode published?

This episode was published on January 4, 2023.

What is this episode about?

Rejuvenate Bio is developing novel therapies to treat aging and age-related diseases through innovative targeted gene therapies and developing treatments to reverse aging and address multiple age-related diseases.

Can I download this Next Sequence episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!